Retraction
Fibrauretine reduces ischemia/reperfusion injury via RISK/eNOS activation
Paper Information
Record ID:
24740
Author(s):
Journal:
Publication Date:
December 03, 2019
Retraction Date:
December 08, 2020
(5.0 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1007/s00210-020-02027-5Additional Notes:
see also: https://link.springer.com/article/10.1007/s00210-021-02056-8
Citations (4)
4
Total Citations1
Post-Retraction(25.0%)
1
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
527
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Advances in research on the protective mechanisms of traditional Chinese medicine (TCM) in myocardial ischaemia-reperfusion injury
Jiexin Zhang, Yonghe Hu, Han Wang et al. (12 authors)
Pharmaceutical Biology
Open Access
Published: May 2022
5 citations
5 citations
527 days after retraction
Retraction Note: Fibrauretine reduces ischemia/reperfusion injury via RISK/eNOS activation
Chunsheng Wang, Rong Chang, Gan Gao et al. (5 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Open Access
Published: Dec 2020
Same day as retraction
Isovaleroylbinankadsurin A ameliorates cardiac ischemia/reperfusion injury through activating GR dependent RISK signaling
Yi-Han Zuo, Yongbei Liu, Chunsong Cheng et al. (8 authors)
Pharmacological Research
Published: May 2020
21 citations
21 citations
207 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #24741
May 29, 2020Quick Stats
Total Citations:
6
Years Since Retraction:
5.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025